<DOC>
	<DOCNO>NCT00876265</DOCNO>
	<brief_summary>This study find investigational product , Belotero , compare second product people facial wrinkle , nasolabial fold . Nasolabial fold wrinkle face go outside nostril edge mouth . Additionally , study determine Belotero safe tolerable corrects facial wrinkle , nasolabial fold .</brief_summary>
	<brief_title>Multicenter Study Safety Effectiveness Dermal Filler , BeloteroÂ® .</brief_title>
	<detailed_description />
	<mesh_term>Facies</mesh_term>
	<criteria>1 . Subjects review signed statement Informed Consent HIPAA authorization prior initiate studyspecific procedure . In addition , subject ask provide separate release use photographs publication . Subjects could refuse photo release without jeopardize eligibility participate study . 2 . Subjects 18 75 year age , race sex . 3 . Female subject postmenopausal least 1 year , hysterectomy , tubal ligation ; , childbearing potential , agree use approve method birth control throughout study ( i.e. , oral/systemic contraceptive , intrauterine device [ IUD ] , spermicide combination barrier method contraception ) , abstinent , monogamous relationship vasectomized partner ; negative urine pregnancy test screen visit . 4 . Subjects bilateral nasolabial fold severity score 2 3 wrinkle SRS assess blind evaluator . 5 . Each subject adequate understanding language ( spoken write English Spanish ) willing comply study requirement . 1 . A personal history allergic/anaphylactic reaction include hypersensitivity local anesthetic ( eg , lidocaine , etc ) , HA preparation , and/or grampositive bacterial protein . 2 . A known history keloid bleed disorder . 3 . An active inflammatory process nasolabial fold area ( skin eruption cyst , pimple , rash , cancerous/precancerous lesion , psoriasis , neurodermatitis , active skin disease ) severe scar might interfere study assessment . 4 . Women pregnant , plan become pregnant study , breastfeed . 5 . Subjects plan undergo major facial surgery course study ( eg , rhinoplasty [ without implant ] , facelift , congenital defect repair , etc ) . 6 . Subjects clinically important disease , judge investigator , within 3 month study ( eg , significant laboratory test abnormality , myocardial infarct , stroke , cancer , connective tissue disease [ scleroderma , systemic lupus erythematous ] , systemic infection , uncontrolled diabetes , etc . ) , include medical condition might require use immunosuppressive medication trial ( eg , severe , uncontrolled asthma , rheumatoid arthritis , autoimmune disease , etc ) . 7 . Severe physical , neurological mental disease . 8 . Excessive facial hair might interfere evaluation wrinkle assessment . 9 . Any systemic dermatologic disorder , , opinion investigator , would interfere study result increase risk adverse event ( AEs ) . 10 . Subjects use exclusionary medications/treatments . 11 . Participation clinical investigation within 30 day prior first plan device administration trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Facial wrinkle</keyword>
	<keyword>Nasolabial fold</keyword>
</DOC>